CompanyDrug

Simcere Affiliate Shanghai Simnova Biotech Gets China Nod for CAR-T Therapy SNC109

CompanyDeals

Biocytogen and Lepu Biotechnology Develop WT1-Targeted Trispecific Antibody for Cancer Treatment

CompanyDeals

Aidea Pharmaceutical Co. Terminates ACC006 Technology Transfer Deal with Lixin Bio

CompanyDeals

AstraZeneca to Acquire China’s Gracell Biotechnologies in $1.2 Billion Deal

Policy / Regulatory

China’s NHC Releases Third List of Recommended Generic Drugs for Development

CompanyDrug

FDA Grants Priority Review to MSD and Daiichi Sankyo’s ADC for Lung Cancer

CompanyDeals

AbbVie and Alpine Immune Sciences Halt Early Enrollment in Lupus Trial

Policy / Regulatory

Jiangsu Province Announces Dual Channel Management and Separate Payment Drug List

CompanyDrug

J&J’s Rybrevant-Lazertinib Combo Accepted for FDA Review in NSCLC

Policy / Regulatory

Hunan Province Releases “Dual Channel” Drug Payment List with 226 Products

CompanyDrug

Shanghai Fosun to Exclusively Commercialize Generic Entresto in China

CompanyDrug

Shouyao Holdings Receives Ethical Approval for Phase III Study of ALK Inhibitor SY-3505